8.4% Below Target

The consensus price target for MEDP is $498.86, close to the current price of $460.2 (8.4% implied move). Based on 19 analyst estimates, the stock appears fairly valued near current levels.

MEDP has a consensus rating of "Hold" based on 19 Wall Street analysts. The rating breakdown is mixed, with 12 Hold ratings making up the largest segment. The consensus 12-month price target of $498.86 implies 8.4% upside from current levels.

MEDP trades at a forward P/E of 27.0942x, representing a moderate valuation. With analysts targeting $498.86 (8.4% implied move), the stock appears reasonably valued with upside.

The most bullish Wall Street analyst has a price target of $582 for MEDP, while the most conservative target is $400. The consensus of $498.86 represents the median expectation. Our quantitative valuation model projects a bull case target of $806 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

MEDP is well covered by analysts, with 19 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 12 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month MEDP stock forecast based on 19 Wall Street analysts shows a consensus price target of $498.86, with estimates ranging from $400 (bear case) to $582 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $612, with bear/bull scenarios of $385/$806.

Our quantitative valuation model calculates MEDP's fair value at $612 (base case), with a bear case of $385 and bull case of $806. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 70/100.

MEDP trades at a forward P/E ratio of 27.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 30.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

MEDP appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $498.86 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

MEDP analyst price targets range from $400 to $582, a 36% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $498.86 consensus represents the middle ground. Our model's $385-$806 range provides an independent fundamental perspective.